The U.S. Food and Drug Administration planned to hold a meeting of its independent experts to review the gene therapy, the company said late on Thursday, less than a month after saying it would not do so. Amid U.S. pressure on fentanyl, Mexico raises drug lab raids data Mexico''s army has dramatically revised upward the number of drug lab raids it says it conducted under President Andres Manuel Lopez Obrador, according to government data and leaked military documents reviewed by Reuters.

The U.S. Food and Drug Administration (FDA) on Friday classified the recall of Getinge AB''s heart devices as the most serious type, saying their use may cause injuries or death.

Major players in the vascular graft market are B.Braun, C. R. Bard, Cardinal Health, Cook Medical, Endologix, LeMaitre Vascular, Medtronic Plc, Getinge, Terumo Medical Corporation, and Gore Medical. Major players in the vascular graft market are B.Braun, C. R. Bard, Cardinal Health, Cook Medical, Endologix, LeMaitre Vascular, Medtronic Plc, Getinge, Terumo Medical Corporation, and Gore Medical.

Getinge AB (publ) (OTCPK:GNGBF) Q4 2022 Earnings Conference Call February 1, 2023 4:00 AM ETCompany ParticipantsMattias Perjos - President and Chief Executive OfficerLars Sandstrom - Chief…

The following slide deck was published by Getinge AB (publ) in conjunction with their 2022 Q4 earnings call.

The U.S. Food and Drug Administration ((FDA)) classified the recall of Getinge''s (GNGBF) (GNGBY) heart devices as the agency''s Class 1 recall, the most serious type of recall as their…

https://www.investing.com/news/stock-market-news/fda-classifies-recall-of-getinges-heart-devices-as-most-serious-2988063